Search Publications

Search

per page

Found 444 matches. Displaying 1 - 10

[ 1 - 10 | Next ]

1. Yu WW, Barrett JNP, Tong J, Lin MJ, Marohn M, Devlin JC, Herrera A, Remark J, Levine J, Liu PK, Fang V, Zellmer AM, Oldridge DA, Wherry EJ, Lin JR, Chen JY, Sorger P, Santagata S, Krueger JG, Ruggles K, Wang F, Su C, Koralov SB, Wang J, Chiu ES   Skin immune-mesenchymal interplay within tertiarylymphoid structures promotes autoimmunepathogenesis in hidradenitis suppurativa   IMMUNITY 2024 DEC 10; 57(12):? Full Text | PMID/PMCID

2. Agüero R, Buchanan KL, Navarrete-Dechent C, Marghoob AA, Stein JA, Landy MS, Leachman SA, Linden KG, Garcet S, Krueger JG, Gareau DS   The Impact of Melanoma Imaging Biomarker Cues on Detection Sensitivity and Specificity in Melanoma versus Clinically Atypical Nevi   CANCERS 2024 SEP; 16(17):? Article 3077 Full Text | PMID/PMCID

3. Renert-Yuval Y, Gonzalez J, Garcet S, Williams SC, Moreno A, Krueger JG   Eosinophils in hidradenitis suppurativa patients exhibit pro-inflammatory traits, implicating a potential pathogenic role in the disease   EXPERIMENTAL DERMATOLOGY 2024 JUL; 33(7):? Article e15129 Full Text | PMID/PMCID

4. Li TM, Zyulina V, Seltzer ES, Dacic M, Chinenov Y, Daamen AR, Veiga KR, Schwartz N, Oliver DJ, Cabahug-Zuckerman P, Lora J, Liu Y, Shipman WD, Ambler WG, Taber SF, Onel KB, Zippin JH, Rashighi M, Krueger JG, Anandasabapathy N, Rogatsky I, Jabbari A, Blobel CP, Lipsky PE, Lu TT   The interferon-rich skin environment regulates Langerhans cell ADAM17 to promote photosensitivity in lupus   ELIFE 2024 JUN 11; 13(?):? Article e85914 Full Text | PMID/PMCID

5. Czarnowicki T, David E, Yamamura K, Han J, He H, Pavel AB, Glickman J, Erickson T, Estrada Y, Krueger JG, Rangel SM, Paller AS, Guttman-Yassky E   Evolution of pathologic B-cell subsets and serum environment-specific sIgEs in patients with atopic dermatitis and controls, from infancy to adulthood   ALLERGY 2024 2024 JUL 14; ?(?):? Full Text | PMID/PMCID

6. Catlett IM, Gao L, Hu YH, Banerjee S, Krueger JG   Pharmacodynamic Response to Deucravacitinib, an Oral, Selective, Allosteric TYK2 Inhibitor, in a Global, Phase 2, Randomized, Double-Blind, Placebo-Controlled Psoriasis Trial   DERMATOLOGY AND THERAPY 2024 2024 SEP 16; ?(?):? Full Text | PMID/PMCID

7. Alavi A, Prens EP, Kimball AB, Frew JW, Krueger JG, Mukhopadhyay S, Gao HL, Ranganathan U, Ivanoff NB, Daly ACH, Zouboulis CC   Proof-of-concept study exploring the effect of spesolimab in patients with moderate-to-severe hidradenitis suppurativa: a randomized double-blind placebo-controlled clinical trial   BRITISH JOURNAL OF DERMATOLOGY 2024 2024 APR 5; ?(?):? Full Text | PMID/PMCID

8. Xi L, Garcet S, Ye Z, Hung K, Hassan-Zahraee M, Kieras E, Krueger JG, Hyde C, Peeva E   A shared tissue transcriptome signature and pathways in psoriasis and ulcerative colitis   SCIENTIFIC REPORTS 2022 NOV 17; 12(1):? Article 19740 Full Text | PMID/PMCID

9. Bachelez H, Barker J, Burden AD, Navarini AA, Krueger JG   Generalized pustular psoriasis is a disease distinct from psoriasis vulgaris: evidence and expert opinion   EXPERT REVIEW OF CLINICAL IMMUNOLOGY 2022 OCT 3; 18(10):1033-1047 Full Text | PMID/PMCID

10. Renert-Yuval Y, da Rosa JC, Garcet S, Pavel AB, Bares J, Chima M, Hawkes JE, Gilleaudeau P, Sullivan-Whalen M, Singer GK, Krueger JG, Guttman-Yassky E   Analysis of alopecia areata surveys suggests a threshold for improved patient-reported outcomes   BRITISH JOURNAL OF DERMATOLOGY 2022 OCT; 187(4):539-547 Full Text | PMID/PMCID

[ 1 - 10 | Next ]